From Concept to Medicine - A Comprehensive Drug Development Journey
By Jim Mitchell
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Jim Mitchell
Category: Chemistry
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 270
Description
Welcome to a Complete Drug Development Journey!
Have you ever wondered how groundbreaking medicines go from a scientist’s vision to life-saving treatments in hospitals and pharmacies worldwide? The journey of drug development is an intricate, high-stakes adventure—filled with scientific breakthroughs, regulatory twists, and the relentless pursuit of innovation.
In this podcast, we take you behind the scenes of pharmaceutical research and development, unraveling the complex and fascinating process that transforms a promising compound into a fully approved, market-ready medicine. Each episode is a deep dive into the critical stages of drug development, including:
🔬 Drug Discovery: Where innovation begins—exploring cutting-edge research, target identification, and the quest for the next medical breakthrough.
🧪 Preclinical Testing: Investigating safety, efficacy, and mechanisms of action before a drug ever reaches human trials.
👩⚕️ Clinical Trials: The rigorous, high-stakes world of human testing—what works, what fails, and what it takes to get to the finish line.
📜 Regulatory Approval: Understanding the intricate web of global regulatory agencies, FDA submissions, and the make-or-break moments for new drugs.
🏭 Manufacturing & Scale-Up: From lab to large-scale production—how pharmaceutical companies tackle formulation, stability, and distribution challenges.
💰 Market Access & Commercialization: The economics of drug development—pricing, market dynamics, and the delicate balance between innovation and accessibility.
Whether you're a scientist, industry professional, investor, or simply fascinated by the inner workings of the pharmaceutical world, this podcast brings you expert insights, real-world case studies, and in-depth discussions on the past, present, and future of drug development.
Join us as we demystify the science, strategy, and business behind the medicines that change lives. Subscribe now and be part of the journey!
Access the Notion Template for cGXP Training Modules here: https://www.notion.so/marketplace/templates/cgxp-guidance-and-training-module
***Information in this podcast series is for education only and not meant to construe medical advice. For that, please consult your health care professional.***
| Episode | Date |
|---|---|
|
21 Atorvastatin (S24E21)
|
Aug 24, 2025 |
|
185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The ALCOA+ Standard (S25E5)
|
Aug 24, 2025 |
|
20 Liraglutide (S24E20)
|
Jul 29, 2025 |
|
18 Pioglitazone (S24E18)
|
Jul 29, 2025 |
|
17 Sitagliptin (S24E17)
|
Jul 29, 2025 |
|
19 Exenatide (S24E19)
|
Jul 29, 2025 |
|
16 Glipizide (S24E16)
|
Jul 29, 2025 |
|
184 - Episode 4 - Quality System Regulation (QSR): The Backbone of Medical Device Manufacturing (21 CFR Part 820) (S25E4)
|
Jul 29, 2025 |
|
183 - Episode 3 - Device Classification and Premarket Pathways - Navigating FDA Clearance (S25E3)
|
Jul 27, 2025 |
|
182 - Episode 2 - The Medical Device Development Lifecycle: From Concept to Commercialization (S25E2)
|
Jul 23, 2025 |
|
15 Insulin (S24E15)
|
Jul 20, 2025 |
|
14 Metformin (S24E14)
|
Jul 20, 2025 |
|
13 Clindamycin (S24E13)
|
Jul 20, 2025 |
|
12 Levofloxacin (S24E12)
|
Jul 20, 2025 |
|
11 Ciprofloxacin (S24E11)
|
Jul 20, 2025 |
|
181 - Episode 1 - Introduction to Medical Devices and Their Regulatory Landscape (S25E1)
|
Jul 20, 2025 |
|
Azithromycin (S24E10)
|
Jul 13, 2025 |
|
Erythromycin (S24E9)
|
Jul 13, 2025 |
|
Amoxicillin (S24E8)
|
Jul 13, 2025 |
|
Penicillin (S24E7)
|
Jul 13, 2025 |
|
Celecoxib (Celebrex) (S24E6)
|
Jul 13, 2025 |
|
Diclofenac (S24E5)
|
Jul 07, 2025 |
|
Naproxen (S24E4)
|
Jul 07, 2025 |
|
Ibuprofen (S24E3)
|
Jul 07, 2025 |
|
Acetaminophen (S24E2)
|
Jul 07, 2025 |
|
Aspirin (S24E1)
|
Jul 07, 2025 |
|
63 - Audit Readiness and Continuous Improvement in Clinical Quality Systems (S23E4)
|
Jun 02, 2025 |
|
62 - Documentation, Informed Consent, and Safety Reporting (S23E3)
|
Jun 02, 2025 |
|
61 - Operational Excellence in Clinical Trials Monitoring & Data Management (S23E2)
|
Jun 02, 2025 |
|
60 – cGCP Fundamentals and Regulatory Overview (S23E1)
|
Jun 02, 2025 |
|
59- Data Integrity, Informed Consent, and Recordkeeping in cGCP (S22E5)
|
Jun 02, 2025 |
|
58 - Risk Management and Quality Assurance in Clinical Trials (S22E4)
|
Jun 02, 2025 |
|
57 - Protocol Design, Investigator Responsibilities, and Documentation (S22E3)
|
Jun 02, 2025 |
|
56 - The Historical Evolution of cGCPs (S22E2)
|
Jun 02, 2025 |
|
55 - What are cGCPs? Foundations and Ethical Principles (S22E1)
|
Jun 02, 2025 |
|
54- Compliance, Enforcement, and Audit Mechanisms (S21E5)
|
Jun 02, 2025 |
|
53 – ICH Guidelines and Global Harmonization (S21E4)
|
Jun 02, 2025 |
|
52 - European and International Regulatory Perspectives (S21E3)
|
Jun 02, 2025 |
|
51 – In-Depth Analysis of FDA cGCP Regulations (S21E2)
|
Jun 02, 2025 |
|
50 – Overview of the cGCP Regulatory Landscape (S21E1)
|
Jun 02, 2025 |
|
180 - Season 12 Recap & Closing the Journey (S12E15)
|
Jun 02, 2025 |
|
179 - Preparing for the Unknown (S12E14)
|
Jun 02, 2025 |
|
178 - Future Manufacturing Technologies (S12E13)
|
Jun 02, 2025 |
|
177 - Policy Changes Shaping the Future (S12E12)
|
Jun 02, 2025 |
|
176 - Next-Gen Clinical Trial Designs (S12E11)
|
Jun 02, 2025 |
|
175 - Balancing Innovation and Safety (S12E10)
|
Jun 02, 2025 |
|
174 - Global Collaboration & Open Innovation (S12E9)
|
Jun 02, 2025 |
|
173 - The Evolving Role of Al in R&D (S12E8)
|
Jun 02, 2025 |
|
172 - Sustainability & Green Chemistry in Pharma (S12E7)
|
Jun 02, 2025 |
|
171 - Patient Data & Digital Health Records (S12E6)
|
Jun 02, 2025 |
|
170 - Emerging Trends in Personalized Development (S12E5)
|
Jun 02, 2025 |
|
169 - Regulatory Science of the Future (S12E4)
|
Jun 02, 2025 |
|
168 - Advances in Biotechnology & Gene Therapy (S12E3)
|
Jun 02, 2025 |
|
167 - Precision Medicine & Genomic Innovations (S12E2)
|
Jun 02, 2025 |
|
166 - Future of Drug Discovery (S12E1)
|
Jun 02, 2025 |
|
64 - FDA 2025 Inspection Operations Manual - What to Expect When You’re Expecting… an FDA Inspection (S19E8)
|
May 26, 2025 |
|
49 – Audit Readiness and Advanced Topics (S20E4)
|
May 24, 2025 |
|
48 - Documentation, Lab Practices & Quality Systems (S20E3)
|
May 24, 2025 |
|
47 - Operational Excellence Validation, Equipment & Processes (S20E2)
|
May 24, 2025 |
|
46 – cGMP Fundamentals and Regulatory Overview (S20E1)
|
May 24, 2025 |
|
45 - Current Trends and Future Directions in GMP (S19E7)
|
May 24, 2025 |
|
44 - Preparing for Regulatory Inspections (S19E6)
|
May 24, 2025 |
|
43 - Case Study 2 Example of Successful GMP Implementation (S19E5)
|
May 24, 2025 |
|
42 - Case Study 1 Illustrative GMP Failure (S19E4)
|
May 24, 2025 |
|
41 - Complaint Handling and Product Recalls Protecting Patients (S19E3)
|
May 24, 2025 |
|
40 - Handling Deviations and Non-Conformances (S19E2)
|
May 24, 2025 |
|
39 - Stability Programs and Shelf Life Determination (S19E1)
|
May 24, 2025 |
|
38 – FDA Form 483 Implications and Impact (S18E6)
|
May 24, 2025 |
|
37 – Establishing and Maintaining a GMP Quality Management System (QMS) (S18E5)
|
May 24, 2025 |
|
36 – Audit Findings and Corrective and Preventive Actions (CAPA) (S18E4)
|
May 24, 2025 |
|
35 – Conducting the GMP Audit Best Practices (S18E3)
|
May 24, 2025 |
|
34 - Planning and Preparing for a GMP Audit (S18E2)
|
May 24, 2025 |
|
33 – The Role of GMP Audits in Ensuring Compliance (S18E1)
|
May 24, 2025 |
|
165 - From Lab Bench to Pilot Plant: Navigating the Challenges of Chemical Process Scale-Up (S11E15)
|
May 24, 2025 |
|
164 - Strategic Approaches to Impurity Control in Multi-Step Organic Syntheses (S11E14)
|
May 24, 2025 |
|
163 - Implementing Continuous Flow Reactors for Enhanced Process Safety and Efficiency (S11E13)
|
May 24, 2025 |
|
162 - The Art and Science of Crystallization in Pharmaceutical Development (S11E12)
|
May 24, 2025 |
|
161 - Optimizing Reaction Conditions Through Design of Experiments (DoE) (S11E11)
|
May 24, 2025 |
|
160 - Addressing Impurities and By-Products in Pharmaceutical Process Development (S11E10)
|
May 24, 2025 |
|
159 - Innovations in Crystallization Techniques for Active Pharmaceutical Ingredients (S11E9)
|
May 24, 2025 |
|
158 - Special Feature Sections in Organic Process Research & Development: Hot Topics (S11E8)
|
May 24, 2025 |
|
157 - The Role of Quality by Design (QbD) in Pharmaceutical Development and Manufacturing (S11E7)
|
May 24, 2025 |
|
156 - Overcoming Scale-Up Challenges in Pharmaceutical Process Development (S11E6)
|
May 24, 2025 |
|
155 - Applications of Flow Chemistry in Modern Drug Development (S11E5)
|
May 24, 2025 |
|
154 - Regulatory Considerations for Starting Materials in Drug Substance Development (S11E4)
|
May 24, 2025 |
|
153 - The Evolving Landscape of Continuous Processing in Pharmaceutical Manufacturing (S11E3)
|
May 24, 2025 |
|
152 - Challenges and Strategies in Peptide Drug Synthesis and Manufacturing (S11E2)
|
May 24, 2025 |
|
151 - Rapid Process Development and Scale-Up Using Multiple Reactors (S11E1)
|
May 24, 2025 |
|
21 - Principles of Good Documentation Practices (GDP) (S16E1)
|
May 18, 2025 |
|
32 - Data Management, Records, and Reporting in GLP (S17E6)
|
May 17, 2025 |
|
31 - GLP Protocols and Standard Operating Procedures (S17E5)
|
May 17, 2025 |
|
30 - Test Systems and Test and Reference Items in GLP (S17E4)
|
May 17, 2025 |
|
29 – GLP Requirements for Facilities and Equipment (S17E3)
|
May 17, 2025 |
|
28 – Key Elements of GLP Organization and Personnel (S17E2)
|
May 17, 2025 |
|
27 - Introduction to Good Laboratory Practices (GLP) (S17E1)
|
May 17, 2025 |
|
26 – Electronic Records and Signatures Navigating 21 CFR Part 11 (S16E6)
|
May 17, 2025 |
|
25 - Laboratory Notebooks and Data Recording (S16E5)
|
May 17, 2025 |
|
24 - Batch Records The History of a Batch (S16E4)
|
May 17, 2025 |
|
23 - Standard Operating Procedures (SOPs) Your GMP Blueprints (S16E3)
|
May 17, 2025 |
|
22 – The ALCOA+ Principles Ensuring Data Integrity (S16E2)
|
May 17, 2025 |
|
150 – Season 10 Recap & Vision Forward (S10E15)
|
May 17, 2025 |
|
149 – Future Trends in Digital Pharma (S10E14)
|
May 17, 2025 |
|
148 – Regulatory Considerations for Digital Health (S10E13)
|
May 17, 2025 |
|
147 – Telemedicine & Decentralized Trials (S10E12)
|
May 17, 2025 |
|
146 – Wearable Technology & Patient Monitoring (S10E11)
|
May 17, 2025 |
|
145 – Case Study: Digital Innovation Accelerating R&D (S10E10)
|
May 17, 2025 |
|
144 – Big Data & Real-World Evidence (S10E9)
|
May 17, 2025 |
|
143 – Cloud Computing & Data Security (S10E8)
|
May 17, 2025 |
|
142 – IoT & Smart Manufacturing (S10E7)
|
May 17, 2025 |
|
141 - Real-Time Data Analytics in Clinical Trials (S10E6)
|
May 17, 2025 |
|
140 – Digital Twins in Process Development (S10E5)
|
May 17, 2025 |
|
139 - Blockchain for Supply Chain Transparency (S10E4)
|
May 17, 2025 |
|
138 - Virtual & Augmented Reality in Pharma (S10E3)
|
May 17, 2025 |
|
137 – AI & Machine Learning in Drug Discovery (S10E2)
|
May 17, 2025 |
|
136 - Digital Transformation in Pharma (S10E1)
|
May 17, 2025 |
|
20 - Quality Risk Management: A Proactive Approach (S15E6)
|
May 10, 2025 |
|
19 - Materials Management: From Raw Materials to Finished Products (S15E5)
|
May 10, 2025 |
|
18 - Change Control: Managing Modifications Effectively (S15E4)
|
May 10, 2025 |
|
17 - Equipment Qualification: IQ, OQ, PQ (S15E3)
|
May 10, 2025 |
|
16 - Cleaning Validation: Preventing Cross-Contamination (S15E2)
|
May 10, 2025 |
|
15 - Process Validation: Ensuring Consistent Quality (S15E1)
|
May 10, 2025 |
|
14 – FDA 21 CFR Part 211 Returned and Salvaged Drug Products (S14E11)
|
May 10, 2025 |
|
13 – FDA 21 CFR Part 211 Records and Reports (S14E10)
|
May 10, 2025 |
|
12 – FDA 21 CFR Part 211 Laboratory Controls (S14E9)
|
May 10, 2025 |
|
11 – FDA 21 CFR Part 211 Holding and Distribution (S14E8)
|
May 10, 2025 |
|
10 – FDA 21 CFR Part 211 Packaging and Labeling Control (S14E7)
|
May 10, 2025 |
|
9 – FDA 21 CFR Part 211 Production and Process Controls (S14E6)
|
May 10, 2025 |
|
8 – FDA 21 CFR Part 211 Control of Components and Drug Containers (S14E5)
|
May 10, 2025 |
|
7 – FDA 21 CFR Part 211 Equipment (S14E4)
|
May 10, 2025 |
|
6 – FDA 21 CFR Part 211 Buildings and Facilities (S14E3)
|
May 10, 2025 |
|
5 - FDA 21 CFR Part 211 Organization and Personnel (S14E2)
|
May 10, 2025 |
|
4 - Understanding FDA 21 CFR Part 210 (S14E1)
|
May 10, 2025 |
|
3 - Global Regulatory Frameworks and cGMP (S13E3)
|
May 10, 2025 |
|
2 - The Historical Evolution of GMP (S13E2)
|
May 10, 2025 |
|
1 - What are cGMPs? (S13E1)
|
May 10, 2025 |
|
135 – Season 9 Recap & Reflections (S9E15)
|
May 10, 2025 |
|
134 – Integrating AI in Quality Control (S9E14)
|
May 10, 2025 |
|
133 – Emerging Technologies in Analytical Testing (S9E13)
|
May 10, 2025 |
|
132 – Quality Control in Continuous Manufacturing (S9E12)
|
May 10, 2025 |
|
131 - Validation of Analytical Methods (S9E11)
|
May 10, 2025 |
|
130 - Automation in Analytical Labs (S9E10)
|
May 10, 2025 |
|
129 - Case Study: Tackling Complex Impurities (S9E9)
|
May 10, 2025 |
|
128 - Data Integrity in QC (S9E8)
|
May 10, 2025 |
|
127 - Process Analytical Technology (PAT) (S9E7)
|
May 10, 2025 |
|
126 - Stability Testing & Forced Degradation (S9E6)
|
May 10, 2025 |
|
125 - Dissolution Testing & Bioequivalence (S9E5)
|
May 10, 2025 |
|
124 - Spectroscopy & Quality Control (S9E4)
|
May 10, 2025 |
|
123 - Mass Spectrometry in Drug Analysis (S9E3)
|
May 10, 2025 |
|
122 - Innovations in Chromatography (S9E2)
|
May 10, 2025 |
|
121 – Advanced Analytical Techniques Overview (S9E1)
|
May 10, 2025 |
|
120 – Season 8 Recap & Future Outlook (S8E15)
|
May 04, 2025 |
|
119 – Emerging Trends in Regulatory Science (S8E14)
|
May 04, 2025 |
|
118 – Digital Tools in Surveillance (S8E13)
|
May 04, 2025 |
|
117 – Patient Registries & Long-Term Studies (S8E12)
|
May 04, 2025 |
|
116 – Real-World Evidence Impact (S8E11)
|
May 04, 2025 |
|
115 – Labeling Changes & Post-Market Commitments (S8E10)
|
May 04, 2025 |
|
114 – Case Study: Navigating a Regulatory Challenge (S8E9)
|
May 04, 2025 |
|
113 – Regulatory Inspections & Audits (S8E8)
|
May 04, 2025 |
|
112 – Global Regulatory Variations (S8E7)
|
May 04, 2025 |
|
111 – REMS and Risk Mitigation Strategies (S8E6)
|
May 04, 2025 |
|
110 – Adverse Event Reporting Explained (S8E5)
|
May 04, 2025 |
|
109 – Post-Marketing Surveillance (S8E4)
|
May 04, 2025 |
|
108 – Role of Pharmacovigilance (S8E3)
|
May 04, 2025 |
|
107 – FDA & ICH Guidelines Overview (S8E2)
|
May 04, 2025 |
|
106 – Deep Dive into Regulatory Affairs (S8E1)
|
May 04, 2025 |
|
105 – Season 7 Recap & Future Directions (S7E15)
|
Apr 27, 2025 |
|
104 – Advanced Drug Delivery Systems (S7E14)
|
Apr 27, 2025 |
|
103 - Patient-Centric Design in Drug Delivery (S7E13)
|
Apr 27, 2025 |
|
102 - Regulatory Aspects of Formulation (S7E12)
|
Apr 27, 2025 |
|
101 - Packaging, Storage, and Cold Chain (S7E11)
|
Apr 27, 2025 |
|
100 – Case Study: Formulation to Market Success (S7E10)
|
Apr 27, 2025 |
|
99 - Analytical Methods in Formulation Testing (S7E9)
|
Apr 27, 2025 |
|
98 - Quality by Design in Formulation (S7E8)
|
Apr 27, 2025 |
|
97 - Stability Indicating Methods & Shelf-life (S7E7)
|
Apr 27, 2025 |
|
96 - Controlled Release & Targeted Delivery (S7E6)
|
Apr 27, 2025 |
|
95 – Overview of Drug Delivery Technologies (S7E5)
|
Apr 27, 2025 |
|
94 - Formulation Challenges for Biologics & Injectables (S7E4)
|
Apr 27, 2025 |
|
93 – Oral Dosage Formulation Strategies (S7E3)
|
Apr 27, 2025 |
|
92 - Excipients: Roles and Selection (S7E2)
|
Apr 27, 2025 |
|
91 - Fundamentals of Formulation Development (S7E1)
|
Apr 27, 2025 |
|
90 – Season 6 Recap & Integration (S6E15)
|
Apr 20, 2025 |
|
89 – Environmental & Safety Considerations (S6E14)
|
Apr 20, 2025 |
|
88 – Risk Management in Process Scale-Up (S6E13)
|
Apr 20, 2025 |
|
87 – Continuous Manufacturing & Emerging Trends (S6E12)
|
Apr 20, 2025 |
|
86 - Technology Transfer from Lab to Plant (S6E11)
|
Apr 20, 2025 |
|
85 – Process Validation & Regulatory Requirements (S6E10)
|
Apr 20, 2025 |
|
84 – Case Study: Manufacturing a Complex Molecule (S6E9)
|
Apr 20, 2025 |
|
83 – Analytical Methods in Process Development (S6E8)
|
Apr 20, 2025 |
|
82 – Impurity Profiling & Control Strategies (S6E7)
|
Apr 20, 2025 |
|
81 – Crystallization and Solid Form Selection (S6E6)
|
Apr 20, 2025 |
|
80 – Purification & Isolation Techniques (S6E5)
|
Apr 20, 2025 |
|
79 – Reactor Design & Scale-Up Challenges (S6E4)
|
Apr 20, 2025 |
|
78 – Process Optimization & QbD Principles (S6E3)
|
Apr 20, 2025 |
|
77 – Process Chemistry: From Bench to Plant (S6E2)
|
Apr 20, 2025 |
|
76 – Introduction to Drug Manufacturing & Scale-Up (S6E1)
|
Apr 20, 2025 |
|
75 – Season 5 Recap & Lessons Learned (S5E15)
|
Apr 14, 2025 |
|
74 - Global Regulatory Harmonization (S5E14)
|
Apr 14, 2025 |
|
73 - Handling Regulatory Feedback & Resubmissions (S5E13)
|
Apr 14, 2025 |
|
72 - Post-Approval Commitments and Phase IV (S5E12)
|
Apr 14, 2025 |
|
71 - Accelerated Approval & Breakthrough Therapies (S5E11)
|
Apr 14, 2025 |
|
70 - Labeling, Risk Management, and REMS (S5E10)
|
Apr 14, 2025 |
|
69 - Advisory Committees & Public Hearings (S5E9)
|
Apr 14, 2025 |
|
68 - Regulatory Review: What the FDA Expects (S5E8)
|
Apr 14, 2025 |
|
67 – NDA/BLA Submission Process (S5E7)
|
Apr 14, 2025 |
|
66 – Phase 3 Success: A Case Study (S5E6)
|
Apr 14, 2025 |
|
65 - Managing Adverse Events in Large Trials (S5E5)
|
Apr 14, 2025 |
|
64 - Global Clinical Trials & Coordination (S5E4)
|
Apr 14, 2025 |
|
63 - Statistical Considerations in Phase 3 (S5E3)
|
Apr 14, 2025 |
|
62 - Designing Robust Phase 3 Studies (S5E2)
|
Apr 14, 2025 |
|
61 - Phase 3 - Large-Scale Efficacy Trials Overview (S5E1)
|
Apr 14, 2025 |
|
60 - Season 4 Recap & Bridging to Later Phases (S4E15)
|
Apr 06, 2025 |
|
59 – Real-World Examples (S4E14)
|
Apr 06, 2025 |
|
58 – Communication with Regulators in Early Trials (S4E13)
|
Apr 06, 2025 |
|
57 - Data Analysis in Early Trials (S4E12)
|
Apr 06, 2025 |
|
56 - Monitoring Safety and Efficacy in Phase 2 (S4E11)
|
Apr 06, 2025 |
|
55 - Patient Recruitment & Ethics in Early Trials (S4E10)
|
Apr 06, 2025 |
|
54 - Adaptive Designs in Early Trials (S4E9)
|
Apr 06, 2025 |
|
53 - Biomarkers in Phase 2 Trials (S4E8)
|
Apr 06, 2025 |
|
52 – Phase 2 Trial Design & Endpoints (S4E7)
|
Apr 06, 2025 |
|
51 - Transitioning to Phase 2 - Efficacy Focus (S4E6)
|
Apr 06, 2025 |
|
50 – Phase 1 Case Study & Lessons Learned (S4E5)
|
Apr 06, 2025 |
|
49 – Dose Escalation & Determining MTD (S4E4)
|
Apr 06, 2025 |
|
48 – PK/PD in Phase 1 (S4E3)
|
Apr 06, 2025 |
|
47 - Designing Phase 1 Safety Trials (S4E2)
|
Apr 06, 2025 |
|
46 – Phase 1: First-in-Human Studies Overview (S4E1)
|
Apr 06, 2025 |
|
45 - Season 3 Recap & Transition to Clinical Trials (S3E15)
|
Mar 30, 2025 |
|
44 - Risk Management in Preclinical Phase (S3E14)
|
Mar 30, 2025 |
|
43 - Integrating Preclinical Data for IND (S3E13)
|
Mar 30, 2025 |
|
42 - Case Study: Preclinical Success Story (S3E12)
|
Mar 30, 2025 |
|
41 - Preclinical Regulatory Interactions (S3E11)
|
Mar 30, 2025 |
|
40 – Immunogenicity Assessment in Biologics (S3E10)
|
Mar 30, 2025 |
|
39 - Stability Testing in Preclinical Phase (S3E9)
|
Mar 30, 2025 |
|
38 - Bioanalytical Method Development (S3E8)
|
Mar 30, 2025 |
|
37 - CMC Considerations in Preclinical Stage (S3E7)
|
Mar 30, 2025 |
|
36 - IND-Enabling Studies Overview (S3E6)
|
Mar 30, 2025 |
|
35 - Preclinical Efficacy Models (S3E5)
|
Mar 30, 2025 |
|
34 - Dose Range Finding Studies (S3E4)
|
Mar 30, 2025 |
|
33 - Safety Pharmacology & Off-Target Screening (S3E3)
|
Mar 30, 2025 |
|
32 - Pharmacokinetics in Preclinical Testing (S3E2)
|
Mar 30, 2025 |
|
31 - Preclinical Toxicology Studies (S3E1)
|
Mar 30, 2025 |
|
30- Season 2 Recap and Integration (S2E15)
|
Mar 23, 2025 |
|
29 - Preclinical Preparation and IND Planning (S2E14)
|
Mar 23, 2025 |
|
28 - Selecting a Development Candidate (S2E13)
|
Mar 23, 2025 |
|
27 - Early Safety Screening (ADME-Tox) (S2E12)
|
Mar 23, 2025 |
|
26 - Challenges in Early Discovery (S2E11)
|
Mar 23, 2025 |
|
25- Case Study: A Drug Discovery Success (S2E10)
|
Mar 23, 2025 |
|
24 - Natural Products and Drug Discovery (S2E9)
|
Mar 23, 2025 |
|
23 - Drug-like Properties & ADME (S2E8)
|
Mar 23, 2025 |
|
22 - Medicinal Chemistry 101: SAR (S2E7)
|
Mar 23, 2025 |
|
21 - Hit-to-Lead and Lead Optimization (S2E6)
|
Mar 23, 2025 |
|
20 - Computational Drug Design & Virtual Screening (S2E5)
|
Mar 23, 2025 |
|
19- Fragment-Based Drug Discovery (S2E4)
|
Mar 23, 2025 |
|
18 – High-Throughput Screening (S2E3)
|
Mar 23, 2025 |
|
17- Target Validation Techniques (S2E2)
|
Mar 23, 2025 |
|
16- Selecting the Right Drug Target (S2E1)
|
Mar 23, 2025 |
|
15- Season 1 Recap and Future Preview (S1E15)
|
Mar 17, 2025 |
|
14-Team Science: Collaboration in R&D (S1E14)
|
Mar 17, 2025 |
|
13 - Risk and Failure in Drug Development (S1E13)
|
Mar 17, 2025 |
|
12 - Funding and Economics of Drug Development (S1E12)
|
Mar 17, 2025 |
|
11- Patents and Intellectual Property (S1E11)
|
Mar 17, 2025 |
|
10 - Formulation and Drug Delivery Basics (S1E10)
|
Mar 17, 2025 |
|
9 - Basics of Drug Manufacturing (S1E9)
|
Mar 17, 2025 |
|
8 - Regulatory Affairs 101 (S1E8)
|
Mar 17, 2025 |
|
7- Clinical Trial Phases Overview (S1E7)
|
Mar 17, 2025 |
|
6- Preclinical Research Overview (S1E6)
|
Mar 17, 2025 |
|
5 – Overview of Drug Discovery Process (S1E5)
|
Mar 17, 2025 |
|
4 - Pharmacology Basics: How Drugs Work (S1E4)
|
Mar 17, 2025 |
|
3 - From Idea to Target Selection (S1E3)
|
Mar 17, 2025 |
|
2- History of Drug Discovery (S1E2)
|
Mar 17, 2025 |
|
1 - Introduction to Drug Development (S1E1)
|
Mar 17, 2025 |